| Description |
1 online resource (1298 pages) |
| Contents |
Intro -- Prelims -- Section- I -- Chapter-001_Development of Cardiology in India Where are We Today -- Chapter-002_Antiplatelets and Antithrombotics after DES What Next -- Chapter-003_Impact of Kidney Disease on the Outcome and Management of Acute Coronary Syndrome -- Chapter-004_Antiplatelet Drug-resistance in Asian Population -- Chapter-005_Gold or Old Standard New Insights on Aspirin in Cardiovascular Diseases (CVD) Prevention -- Chapter-006_Changing Landscape of Oral Anticoagulants The Last Pieces of the Puzzle -- Chapter-007_Top Ten Most Promising New and Future Therapies in Cardiology Status Report 2014 -- Chapter-008_A Cardiologists Viewpoint on Gliptins The New Star on the Horizon of Diabetes -- Chapter-009_Statins as Primary Preventive Strategy -- Chapter-010_Management of Atherogenic Dyslipidemia Triad Indian Perspective -- Chapter-011_Lipid Management Beyond Statins Targeting HDL and TG Challenges 2014 -- Chapter-012_Management of Hypertriglyceridemia and Cardiovascular Risk Reduction -- Chapter-013_Beta-blockers and Coronary Artery Disease Status 2014 -- Chapter-014_Statin Guidelines Controversies to Consensus (What to Follow in 2014) -- Chapter-015_ARBs and CVD Protection New Dimension 2014 -- Chapter-016_Amiodarone and Cardiovascular Disease Protection Clinical Implications 2014 -- Chapter-017_Gaps and Challenges in Antiplatelet Therapy Indian Perspective -- Chapter-018_Triple Antiplatelet Therapy in Acute Coronary Syndrome in 2014 -- Chapter-019_Drug-Drug Interactions in Cardiology -- Chapter-020_Pharmacoinvasive Strategy in the Treatment of STEMI -- Chapter-021_Post-PTCA and Post-CABG Care What is New in 2014 -- Chapter-022_Acute Coronary Syndrome Management Strategies Recent Advances 2014 -- Section- II -- Chapter-023_Genetics and Coronary Artery Disease-Challenges -- Chapter-024_Coronary Artery Disease Risk Factor Stratification |
|
Chapter-025_Vitamin D and Cardiovascular Disease -- Chapter-026_Tobacco and Heart -- Chapter-027_Stress and Heart -- Chapter-028_Role of Psychosocial Factors and Relaxation Techniques in the Etiology and Prevention of Cardiovascular Diseases -- Chapter-029_Trans Fat and Cardiovascular Disease -- Chapter-030_Homocysteine and Coronary Artery Disease -- Chapter-031_State-of-the-art Review on Metabolic Syndrome, Diabetes, and Cardiovascular Disease -- Chapter-032_Vulnerable Plaque in a Vulnerable Patient How to Manage -- Chapter-033_Microvascular CAD Management Issues 2014 -- Chapter-034_Hormone Replacement Therapy and Heart -- Chapter-035_Lifestyle and Coronary Artery Disease -- Chapter-036_Using Health Behavior Change Theory to Guide Health Promotion to Prevent Noncommunicable Diseases in India -- Section- III -- Chapter-037_Nutrition and Heart -- Chapter-038_CoQ10 and CVD Risk Reduction 2014 -- Chapter-039_CoQ10 in CHF and CAD Potentials and Challenges Ahead -- Chapter-040_Edible Oils in Cardiovascular Disease Protection -- Chapter-041_Management of Obesity By Optimizing Nutrition -- Section- IV -- Chapter-042_Coronary Artery Disease and Biomarkers -- Chapter-043_Electrocardiogram Pitfalls in Diagnosis and Artifacts -- Chapter-044_Echocardiography Beginning, Present, and FutureEchocardiography Beginning, Present, and Future -- Chapter-045_Stress Echocardiography and Coronary Artery Disease -- Chapter-046_Stress Myocardial Perfusion Imaging -- Chapter-047_LV Diastolic Function Evaluation What is Practical -- Chapter-048_Echocardiographic Evaluation in Elderly What is New -- Chapter-049_Myocardial Contrast Echocardiography Usefulness and Pitfalls -- Chapter-050_Echocardiography and Post-MI Complications -- Chapter-051_Three-dimensional Echocardiography Is it Superior to Two-dimensional Echocardiography for Valvular Heart Disease |
|
Chapter-052_Strain and Strain Rate Imaging Clinical Implications 2014 -- Chapter-053_Need of Cardiac Evaluation in Obesity -- Section- V -- Chapter-054_Management of Acute Myocardial Infarction in 2014 -- Chapter-055_Thrombolysis in Acute Myocardial Infarction Which Agent is the Right Choice -- Chapter-056_Primary Angioplasty in 2014 -- Chapter-057_Thrombus Aspiration During Primary Percutaneous Coronary Angioplasty -- Chapter-058_Cardiogenic Shock in Acute Myocardial Infarction -- Chapter-059_Post-MI Risk Stratification and Cardiac Rehabilitation -- Chapter-060_Revascularization in Acute Myocardial Infarction Patients 24 Hours after Thrombolysis -- Chapter-061_Thrombolytic Therapy in STEMI Interventions -- Section- VI -- Chapter-062_Chronic Total Occlusion (CTO) Strategies and Wiring Techniques -- Chapter-063_Chronic Total Occlusion Management Strategies 2014 -- Chapter-064_Radial Angioplasty Tips and Tricks -- Chapter-065_Guidelines for PCI 2014 Training for Percutaneous Coronary Intervention Appropriateness, Indications and Directions -- Chapter-066_Complex Coronary Angioplasty Procedure Tips and Tricks -- Chapter-067_Drug-eluting Stents Differing Platforms and Outcome -- Chapter-068_Role of Rotational Atherectomy in Percutaneous Coronary Interventions -- Chapter-069_Can We Predict Stent Thrombosis and So Prevent It -- Chapter-070_Biovascular Scaffolds New Dimension 2014 -- Chapter-071_Indigenous Stents Examining the Clinical Data on New Technologies -- Chapter-072_Hybrid Coronary Revascularization An Integrated Best of Both Worlds Approach to Revascularization -- Chapter-073_Management of Coronary Stent Restenosis New Dimensions -- Chapter-074_Saphenous Vein Grafts Intervention Challenges 2014 -- Section- VII -- Chapter-075_Carotid Evaluation How to Do, 2014 -- Chapter-076_Carotid Intervention Current Status and Future Direction |
|
Chapter-077_Aortic Evaluation and Interventions Status 2014 -- Chapter-078_Peripheral Vascular Evaluation and Intervention -- Chapter-079_Chronic Lower Limb Ischemia Management Strategies -- Chapter-080_Erectile Dysfunction and Coronary Artery Disease -- Section- VIII -- Chapter-081_Biomarkers in Heart Failure Newer Horizon -- Chapter-082_Echo and Diastolic Heart Failure -- Chapter-083_BNP Evaluation Guidelines in CHF -- Chapter-084_Anemia in Chronic Heart Failure -- Chapter-085_When to Revascularize in Heart Failure -- Chapter-086_Acute Decompensated Heart Failure -- Chapter-087_Managing Comorbidities in Heart Failure -- Chapter-088_CHF and CKD-Double Jeopardy How to Manage -- Chapter-089_Heart Failure Management in Women Is it Different -- Chapter-090_Left Ventricular Assist Devices New Frontiers 2014 -- Section- IX -- Chapter-091_Approach to a Newly Diagnosed Hypertensive Patient -- Chapter-092_Ambulatory BP Monitoring Is It Really Essential -- Chapter-093_Cardiovascular Risk in Hypertension How to Manage It -- Chapter-094_Role of Echocardiography in Hypertension -- Chapter-095_Nonpharmacological Management of Hypertension 2014 -- Chapter-096_Resistant Hypertension Clinical Evaluation and Management -- Chapter-097_Indian Practical Guidelines for Management of Hypertension -- Chapter-098_Choosing the Right Drug for Your Hypertensive Patient A Look at Comorbidities -- Chapter-099_Renal Denervation Present Status and Future Direction -- Chapter-100_Recent Advances in Hypertension Management for Cardiovascular Disease Prevention -- Chapter-101_Hypertension Paradoxes -- Chapter-102_Hypertension Management Strategy in Renal Artery Stenosis -- Chapter-103_Central Aortic Blood Pressure as a Prognostic Marker in Hypertension -- Section- X -- Chapter-104_TAVR Present Status and Challenges Ahead |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Print version record |
| Subject |
Cardiology.
|
|
Cardiovascular system -- Diseases.
|
|
Cardiovascular Diseases
|
|
Cardiology
|
|
Cardiovascular system -- Diseases.
|
|
Cardiology.
|
| SUBJECT |
India |
| Form |
Electronic book
|
| Author |
Ramakrishnan, S
|
|
Pancholia, AK
|
| ISBN |
9789386150080 |
|
9386150085 |
|
